{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T13:40:46Z","timestamp":1793540446445,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s11596-024-2914-y","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T01:01:24Z","timestamp":1721696484000},"page":"902-911","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Protective Effects of Berberine on Nonalcoholic Fatty Liver Disease in db\/db Mice via AMPK\/SIRT1 Pathway Activation"],"prefix":"10.1007","volume":"44","author":[{"given":"Cheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-cui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"issue":"3","key":"2914_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease\u2013A global public health perspective. J Hepatol, 2019,70(3):531\u2013544","journal-title":"J Hepatol"},{"issue":"9","key":"2914_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol, 2022,7(9):851\u2013861","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"2914_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.mayocp.2019.08.027","volume":"95","author":"D Pastori","year":"2020","unstructured":"Pastori D, Sciacqua A, Marcucci R, et al. Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation. Mayo Clin Proceed, 2020,95(3):513\u2013520","journal-title":"Mayo Clin Proceed"},{"issue":"6","key":"2914_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.amjms.2020.06.020","volume":"360","author":"EW Abd El-Wahab","year":"2020","unstructured":"Abd El-Wahab EW, Zein El-Abedin RA, Ahmed WM, et al. Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting. Am J Med Sci, 2020,360(6):662\u2013677","journal-title":"Am J Med Sci"},{"key":"2914_CR5","doi-asserted-by":"publisher","first-page":"1050709","DOI":"10.3389\/fendo.2022.1050709","volume":"13","author":"K Guo","year":"2022","unstructured":"Guo K, Xu S, Zeng Z. \u201cLiver\u2013gut\u201d axis: A target of traditional Chinese medicine for the treatment of nonalcoholic fatty liver disease. Front Endocrinol, 2022,13:1050709","journal-title":"Front Endocrinol"},{"issue":"4","key":"2914_CR6","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.bbrc.2019.12.131","volume":"523","author":"CC Sun","year":"2020","unstructured":"Sun CC, Zhang CY, Duan JX, et al. PTUPB ameliorates high-fat diet-induced nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome activation in mice. Biochem Biophys Res Commun, 2020,523(4):1020\u20131026","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2914_CR7","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.clnu.2020.09.026","volume":"40","author":"Y Lan","year":"2021","unstructured":"Lan Y, Wu S, Wang Y, et al. Association between blood copper and nonalcoholic fatty liver disease according to sex. Clin Nutr, 2021,40(4):2045\u20132052","journal-title":"Clin Nutr"},{"key":"2914_CR8","doi-asserted-by":"publisher","first-page":"155765","DOI":"10.1016\/j.metabol.2023.155765","volume":"152","author":"JC B\u00f3rquez","year":"2024","unstructured":"B\u00f3rquez JC, D\u00edaz-Castro F, Pino-de La Fuente F, et al. Mitofusin-2 induced by exercise modifies lipid droplet-mitochondria communication, promoting fatty acid oxidation in male mice with NAFLD. Metabolism, 2024,152:155765","journal-title":"Metabolism"},{"issue":"7","key":"2914_CR9","doi-asserted-by":"publisher","first-page":"166815","DOI":"10.1016\/j.bbadis.2023.166815","volume":"1869","author":"Y You","year":"2023","unstructured":"You Y, Liang W. SIRT1 and SIRT6: The role in aging-related diseases. Biochim Biophys Acta Mol Basis Dis, 2023,1869(7):166815","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"8","key":"2914_CR10","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1210\/me.2007-0079","volume":"21","author":"H Yamamoto","year":"2007","unstructured":"Yamamoto H, Schoonjans K, Auwerx J. Sirtuin functions in health and disease. Mol Endocrinol, 2007,21(8):1745\u20131755","journal-title":"Mol Endocrinol"},{"key":"2914_CR11","doi-asserted-by":"publisher","first-page":"113927","DOI":"10.1016\/j.bcp.2020.113927","volume":"175","author":"Y Zeng","year":"2020","unstructured":"Zeng Y, Hua YQ, Wang W, et al. Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin. Biochem Pharmacol, 2020,175:113927","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2914_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/13813455.2021.1956976","volume":"130","author":"A Mihanfar","year":"2024","unstructured":"Mihanfar A, Akbarzadeh M, Ghazizadeh Darband S, et al. SIRT1: a promising therapeutic target in type 2 diabetes mellitus. Arch Physiol Biochem, 2024,130(1):13\u201328","journal-title":"Arch Physiol Biochem"},{"key":"2914_CR13","doi-asserted-by":"publisher","first-page":"107037","DOI":"10.1016\/j.phrs.2023.107037","volume":"199","author":"S Shen","year":"2024","unstructured":"Shen S, Shen M, Kuang L, et al. SIRT1\/SREBPs-mediated regulation of lipid metabolism. Pharmacol Res, 2024,199:107037","journal-title":"Pharmacol Res"},{"issue":"3","key":"2914_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/hep.32152","volume":"75","author":"R Ren","year":"2022","unstructured":"Ren R, He Y, Ding D, et al. Aging exaggerates acute-on-chronic alcohol-induced liver injury in mice and humans by inhibiting neutrophilic sirtuin 1-C\/EBP\u03b1-miRNA-223 axis. Hepatology, 2022,75(3):646\u2013660","journal-title":"Hepatology"},{"issue":"5","key":"2914_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","volume":"9","author":"BB Zhang","year":"2009","unstructured":"Zhang BB, Zhou G, Li C. AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome. Cell Metab, 2009,9(5):407\u2013416","journal-title":"Cell Metab"},{"key":"2914_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ejmech.2014.04.010","volume":"79","author":"J Liu","year":"2014","unstructured":"Liu J, Chen D, Liu P, et al. Discovery, synthesis, and structure\u2013activity relationships of 20(S)-protopanaxadiol (PPD) derivatives as a novel class of AMPK\u03b12\u03b21\u03b31 activators. Eur J Med Chem, 2014,79:340\u2013349","journal-title":"Eur J Med Chem"},{"issue":"7241","key":"2914_CR17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nature07813","volume":"458","author":"C Cant\u00f3","year":"2009","unstructured":"Cant\u00f3 C, Gerhart Hines Z, Feige JN, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature, 2009,458(7241):1056\u20131060","journal-title":"Nature"},{"key":"2914_CR18","doi-asserted-by":"publisher","first-page":"105177","DOI":"10.1016\/j.rvsc.2024.105177","volume":"169","author":"D Zhang","year":"2024","unstructured":"Zhang D, Ding H, Liu C, et al. Circulating exosome-mediated AMPK\u03b1\u2013SIRT1 pathway regulates lipid metabolism disorders in calf hepatocytes. Vet Res, 2024,169:105177","journal-title":"Vet Res"},{"key":"2914_CR19","doi-asserted-by":"publisher","first-page":"155005","DOI":"10.1016\/j.phymed.2023.155005","volume":"119","author":"X Yin","year":"2023","unstructured":"Yin X, Liu Z, Wang J. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis. Phytomedicine, 2023,119:155005","journal-title":"Phytomedicine"},{"key":"2914_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.aninu.2023.03.010","volume":"14","author":"NN Zhou","year":"2023","unstructured":"Zhou NN, Wang T, Lin YX, et al. Uridine alleviates high-carbohydrate diet-induced metabolic syndromes by activating sirt1\/AMPK signaling pathway and promoting glycogen synthesis in Nile tilapia (Oreochromis niloticus). Ani Nutr, 2023,14:56\u201366","journal-title":"Ani Nutr"},{"issue":"1","key":"2914_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12906-019-2671-9","volume":"19","author":"K Fang","year":"2019","unstructured":"Fang K, Wu F, Chen G, et al. Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK\/ACC\/CPT-1A and SREBP-1c\/FAS signaling pathways in LO2 cells. BMC Complem Altern M, 2019,19(1):255","journal-title":"BMC Complem Altern M"},{"issue":"2","key":"2914_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3892\/mmr.2023.13141","volume":"29","author":"A Xu","year":"2024","unstructured":"Xu A, Wang L, Luo M, et al. Overexpression of salusin-\u03b2 downregulates adipoR1 expression to prevent fatty acid oxidation in HepG2 cells. Mol Med Rep, 2024,29(2):18","journal-title":"Mol Med Rep"},{"issue":"5","key":"2914_CR23","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1159\/000493650","volume":"49","author":"CJ Liou","year":"2018","unstructured":"Liou CJ, Wei CH, Chen YL, et al. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1\/AMPK and Fatty Acid \u03b2-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice. Cell Physiol Biochem, 2018,49(5):1870\u20131884","journal-title":"Cell Physiol Biochem"},{"key":"2914_CR24","doi-asserted-by":"publisher","first-page":"117050","DOI":"10.1016\/j.jep.2023.117050","volume":"318","author":"X Wang","year":"2024","unstructured":"Wang X, Liang F, Dai Z, et al. Combination of Coptis chinensis polysaccharides and berberine ameliorates ulcerative colitis by regulating gut microbiota and activating AhR\/IL-22 pathway. J Ethnopharmacol, 2024,318:117050","journal-title":"J Ethnopharmacol"},{"key":"2914_CR25","doi-asserted-by":"publisher","first-page":"1269605","DOI":"10.3389\/fphar.2023.1269605","volume":"14","author":"F Di Pierro","year":"2023","unstructured":"Di Pierro F, Sultana R, Eusaph AZ, et al. Effect of Berberine Phytosome on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multicentric, open-label clinical trial. Front Pharmacol, 2023,14:1269605","journal-title":"Front Pharmacol"},{"issue":"10","key":"2914_CR26","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2174\/0929867330666230207112539","volume":"31","author":"A Gasmi","year":"2024","unstructured":"Gasmi A, Asghar F, Zafar S, et al. Berberine: Pharmacological Features in Health, Disease and Aging. Curr Med Chem, 2024,31(10):1214\u20131234","journal-title":"Curr Med Chem"},{"key":"2914_CR27","doi-asserted-by":"publisher","first-page":"117829","DOI":"10.1016\/j.jep.2024.117829","volume":"324","author":"Y Tang","year":"2024","unstructured":"Tang Y, Gao Y, Nie K, et al. Jiao-tai-wan and its effective component-berberine improve diabetes and depressive disorder through the cAMP\/PKA\/CREB signaling pathway. J Ethnopharmacol, 2024,324:117829","journal-title":"J Ethnopharmacol"},{"key":"2914_CR28","first-page":"14:1283784","volume":"15","author":"Y Cai","year":"2023","unstructured":"Cai Y, Yang Q, Yu Y, et al. Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review. Front Pharmacol, 2023,15:14:1283784","journal-title":"Front Pharmacol"},{"issue":"1","key":"2914_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jep.2009.08.009","volume":"126","author":"J Tang","year":"2009","unstructured":"Tang J, Feng Y, Tsao S, et al. Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J Ethnopharmacol, 2009,126(1):5\u201317","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"2914_CR30","doi-asserted-by":"publisher","first-page":"e23278","DOI":"10.1002\/jbt.23278","volume":"37","author":"N Devarajan","year":"2023","unstructured":"Devarajan N, Nathan J, Mathangi R, et al. Pharmacotherapeutic values of berberine: A Chinese herbal medicine for the human cancer management. J Biochem Mol Toxic, 2023,37(3):e23278","journal-title":"J Biochem Mol Toxic"},{"issue":"8","key":"2914_CR31","doi-asserted-by":"publisher","first-page":"e0134172","DOI":"10.1371\/journal.pone.0134172","volume":"10","author":"HM Yan","year":"2015","unstructured":"Yan HM, Xia MF, Wang Y, et al. Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease. PLoS One, 2015,10(8):e0134172","journal-title":"PLoS One"},{"issue":"1","key":"2914_CR32","first-page":"294","volume":"36","author":"L Nejati","year":"2022","unstructured":"Nejati L, Movahedi A, Salari GR, et al. The Effect of Berberine on Lipid Profile, Liver Enzymes, and Fasting Blood Glucose in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): A Randomized Controlled Trial. MJIRI, 2022,36(1):294\u2013301","journal-title":"MJIRI"},{"issue":"17","key":"2914_CR33","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.3390\/nu14173459","volume":"14","author":"A Koperska","year":"2022","unstructured":"Koperska A, Wesolek A, Moszak M, et al. Berberine in Non-Alcoholic Fatty Liver Disease-A Review. Nutrients, 2022,14(17):3459","journal-title":"Nutrients"},{"key":"2914_CR34","doi-asserted-by":"publisher","first-page":"e12096","DOI":"10.1590\/1414-431x2022e12096","volume":"55","author":"Y Dai","year":"2022","unstructured":"Dai Y, Zhu W, Zhou J, et al. The combination of berberine and evodiamine ameliorates high-fat diet-induced nonalcoholic fatty liver disease associated with modulation of gut microbiota in rats. Braz J Med Biol Res, 2022,55:e12096","journal-title":"Braz J Med Biol Res"},{"key":"2914_CR35","doi-asserted-by":"publisher","first-page":"12343000","DOI":"10.3389\/fphar.2023.1234300","volume":"14","author":"H Rafiei","year":"2023","unstructured":"Rafiei H, Yeung M, Kowalski S, et al. Development of a novel human triculture model of nonalcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis. Front Pharmacol, 2023,14:12343000","journal-title":"Front Pharmacol"},{"issue":"7","key":"2914_CR36","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/biology12070973","volume":"12","author":"AR Utami","year":"2023","unstructured":"Utami AR, Maksum IP, Deawati Y. Berberine and Its Study as an Antidiabetic Compound. Biology, 2023,12(7):973","journal-title":"Biology"},{"key":"2914_CR37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.neuropharm.2017.08.013","volume":"125","author":"H Zhang","year":"2017","unstructured":"Zhang H, Zhao C, Cao G, et al. Berberine modulates amyloid-\u03b2 peptide generation by activating AMP-activated protein kinase. Neuropharmacology, 2017,125:408\u2013417","journal-title":"Neuropharmacology"},{"key":"2914_CR38","doi-asserted-by":"publisher","first-page":"goad032","DOI":"10.1093\/gastro\/goad032","volume":"11","author":"P Wang","year":"2023","unstructured":"Wang P, Li R, Li Y, et al. Berberine alleviates nonalcoholic hepatic steatosis partially by promoting SIRT1 deacetylation of CPT1A in mice. Gastroenterol Rep (Oxf), 2023,11:goad032","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"2914_CR39","doi-asserted-by":"publisher","first-page":"116435","DOI":"10.1016\/j.carbpol.2020.116435","volume":"243","author":"X Liu","year":"2020","unstructured":"Liu X, Wang K, Zhou J, et al. Metformin and Berberine suppress glycogenolysis by inhibiting glycogen phosphorylase and stabilizing the molecular structure of glycogen in db\/db mice. Carbohydr Polym, 2020,243:116435","journal-title":"Carbohydr Polym"},{"issue":"4","key":"2914_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","volume":"7","author":"EM Brunt","year":"2010","unstructured":"Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol, 2010,7(4):195\u2013203","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"2914_CR41","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1039\/c7tx00326a","volume":"7","author":"JE Klaunig","year":"2018","unstructured":"Klaunig JE, Li X, Wang Z. Role of xenobiotics in the induction and progression of fatty liver disease. Toxicol Res, 2018,7(4):664\u2013680","journal-title":"Toxicol Res"},{"key":"2914_CR42","doi-asserted-by":"publisher","first-page":"8416763","DOI":"10.1155\/2017\/8416763","volume":"2017","author":"G Pizzino","year":"2017","unstructured":"Pizzino G, Irrera N, Cucinotta M, et al. Oxidative Stress: Harms and Benefits for Human Health. Oxid Med Cell Longev, 2017,2017:8416763","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"2914_CR43","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies. Nat Med, 2018,24(7):908\u2013922","journal-title":"Nat Med"},{"issue":"1","key":"2914_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s10020-018-0044-3","volume":"24","author":"H Chen","year":"2018","unstructured":"Chen H, Zhou W, Ruan Y, et al. Reversal of angiotensin ll-induced \u03b2-cell dedifferentiation via inhibition of NF-\u03bab signaling. Mol Med, 2018,24(1):43","journal-title":"Mol Med"},{"key":"2914_CR45","doi-asserted-by":"publisher","first-page":"109131","DOI":"10.1016\/j.biopha.2019.109131","volume":"118","author":"W Zhang","year":"2019","unstructured":"Zhang W, Xu JH, Yu T, et al. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db\/db mice. Biomed Pharmacother, 2019,118:109131","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2914_CR46","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12072-011-9320-9","volume":"7","author":"M Ciupi\u0144ska-Kajor","year":"2013","unstructured":"Ciupi\u0144ska-Kajor M, Hartleb M, Kajor M, et al. Hepatic angiogenesis and fibrosis are common features in morbidly obese patients. Hepatol Int, 2013,7(1):233\u2013240","journal-title":"Hepatol Int"},{"issue":"1","key":"2914_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00042737-200601000-00005","volume":"18","author":"RM Ramalho","year":"2006","unstructured":"Ramalho RM, Cortez-Pinto H, Castro RE, et al. Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis. Eur J Gastroenterol Hepatol, 2006,18(1):21\u201329","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"38","key":"2914_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3748\/wjg.v12.i38.6198","volume":"12","author":"A Panasiuk","year":"2006","unstructured":"Panasiuk A, Dzieciol J, Panasiuk B, et al. Expression of p53, Bax and Bcl-2 proteins in hepatocytes in nonalcoholic fatty liver disease. World J Gastroentero, 2006,12(38):5","journal-title":"World J Gastroentero"},{"issue":"1","key":"2914_CR49","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","volume":"7","author":"QJ Wu","year":"2022","unstructured":"Wu QJ, Zhang TN, Chen HH, et al. The sirtuin family in health and disease. Signal Transduct Target Ther, 2022,7(1):402","journal-title":"Signal Transduct Target Ther"},{"key":"2914_CR50","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.2147\/DMSO.S437865","volume":"16","author":"D Meng","year":"2023","unstructured":"Meng D, Zhang F, Yu W, et al. Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver. Diabet Metab Synd Ob, 2023,16:4043\u20134064","journal-title":"Diabet Metab Synd Ob"},{"issue":"3","key":"2914_CR51","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1053\/j.gastro.2013.11.008","volume":"146","author":"H Yin","year":"2014","unstructured":"Yin H, Hu M, Liang X, et al. Deletion of SIRT1 From Hepatocytes in Mice Disrupts Lipin-1 Signaling and Aggravates Alcoholic Fatty Liver. Gastroenterology, 2014,146(3):801\u2013811","journal-title":"Gastroenterology"},{"issue":"9","key":"2914_CR52","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3390\/antiox11091695","volume":"11","author":"B Keshavjee","year":"2022","unstructured":"Keshavjee B, Lambelet V, Coppola H, et al. Stress-Induced Premature Senescence Related to Oxidative Stress in the Developmental Programming of Nonalcoholic Fatty Liver Disease in a Rat Model of Intrauterine Growth Restriction. Antioxidants (Basel), 2022,11(9):1695","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"2914_CR53","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The Nuclear Factor NF-\u03baB Pathway in Inflammation. Cold Spring Harb Perspect Biol, 2009,1(6):a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"12","key":"2914_CR54","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","volume":"23","author":"F Yeung","year":"2004","unstructured":"Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-\u03baB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J, 2004,23(12):2369\u20132380","journal-title":"EMBO J"},{"issue":"13","key":"2914_CR55","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1089\/ars.2017.7373","volume":"28","author":"P Rada","year":"2017","unstructured":"Rada P, Pardo V, Mobasher MA, et al. SIRT1 Controls Acetaminophen Hepatotoxicity by Modulating Inflammation and Oxidative Stress. Antioxid Redox Signal, 2017,28(13):1187\u20131208","journal-title":"Antioxid Redox Signal"},{"issue":"17","key":"2914_CR56","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.3390\/molecules24173084","volume":"24","author":"G Xu","year":"2019","unstructured":"Xu G, Zhao J, Liu H, et al. Melatonin Inhibits Apoptosis and Oxidative Stress of Mouse Leydig Cells via a SIRT1-Dependent Mechanism. Molecules, 2019,24(17):3084","journal-title":"Molecules"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2914-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-024-2914-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2914-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T23:11:34Z","timestamp":1733872294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-024-2914-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2914"],"URL":"https:\/\/doi.org\/10.1007\/s11596-024-2914-y","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}